MTOR and pituitary gland adenoma: The dual mTOR/PI3K inhibitor NVP-BEZ235 reduces cell proliferation and promotes cell death in rat non-functioning pituitary adenomas in vitro and in vivo [84], in growth hormone-secreting GH3 cell lines in vitro, and in primary cell cultures of human prolactinomas [85].